RecruitingPhase 3NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Tupelo, MS · +86 more sites
Lung Cancer clinical trials in Tupelo, MS
2 recruiting lung cancer studies with a site in Tupelo, MS.
RecruitingNot applicableNCT07682597
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
Sponsor: Timothy Mullett
Greenville, MS · Greenwood, MS · Gulfport, MS · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.